Ionis Pharmaceuticals, Inc. (IONS)
43.54
-0.46
(-1.05%)
USD |
NASDAQ |
Oct 02, 16:00
43.60
+0.06
(+0.14%)
Pre-Market: 20:00
Ionis Pharmaceuticals Total Return Level : 43.54 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 43.54 |
| October 01, 2026 | 44.00 |
| September 30, 2026 | 44.65 |
| September 29, 2026 | 45.89 |
| September 28, 2026 | 45.57 |
| September 25, 2026 | 44.50 |
| September 24, 2026 | 43.81 |
| September 23, 2026 | 43.93 |
| September 22, 2026 | 45.75 |
| September 21, 2026 | 44.90 |
| September 18, 2026 | 44.44 |
| September 17, 2026 | 46.75 |
| September 16, 2026 | 44.84 |
| September 15, 2026 | 47.25 |
| September 14, 2026 | 51.44 |
| September 11, 2026 | 54.21 |
| September 10, 2026 | 55.65 |
| September 09, 2026 | 56.02 |
| September 08, 2026 | 56.71 |
| September 04, 2026 | 58.09 |
| September 03, 2026 | 58.13 |
| September 02, 2026 | 61.33 |
| September 01, 2026 | 59.88 |
| August 31, 2026 | 60.36 |
| August 28, 2026 | 61.05 |
| Date | Value |
|---|---|
| August 27, 2026 | 62.43 |
| August 26, 2026 | 63.36 |
| August 25, 2026 | 63.57 |
| August 24, 2026 | 62.04 |
| August 21, 2026 | 59.74 |
| August 20, 2026 | 58.76 |
| August 19, 2026 | 60.80 |
| August 18, 2026 | 59.62 |
| August 17, 2026 | 58.63 |
| August 14, 2026 | 57.24 |
| August 13, 2026 | 55.87 |
| August 12, 2026 | 56.53 |
| August 11, 2026 | 55.42 |
| August 10, 2026 | 56.94 |
| August 07, 2026 | 56.56 |
| August 06, 2026 | 54.49 |
| August 05, 2026 | 54.19 |
| August 04, 2026 | 55.07 |
| August 03, 2026 | 54.49 |
| July 31, 2026 | 51.77 |
| July 30, 2026 | 53.28 |
| July 29, 2026 | 54.04 |
| July 28, 2026 | 55.30 |
| July 27, 2026 | 55.96 |
| July 24, 2026 | 56.55 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Biogen, Inc. | 219.88 |
| BridgeBio Pharma, Inc. | 67.25 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| Pfizer Inc. | 92.99 |